Alan H. Auerbach
2012
In 2012, Alan H. Auerbach earned a total compensation of $29.1M as President and Chief Executive Officer at Puma Biotechnology, a 18,490% increase compared to previous year.
Compensation breakdown
| Bonus | $235,000 |
|---|---|
| Option Awards | $2,600,500 |
| Salary | $470,000 |
| Other | $25,818,686 |
| Total | $29,124,186 |
Auerbach received $25.8M in other compensation, accounting for 89% of the total pay in 2012.
Auerbach also received $235K in bonus, $2.6M in option awards and $470K in salary.
Rankings
In 2012, Alan H. Auerbach's compensation ranked 42nd out of 11,487 executives tracked by ExecPay. In other words, Auerbach earned more than 99.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 42 out of 11,487 | 100th |
Division Manufacturing | 18 out of 4,253 | 100th |
Major group Chemicals And Allied Products | 5 out of 1,198 | 100th |
Industry group Drugs | 5 out of 920 | 100th |
Industry Pharmaceutical Preparations | 4 out of 700 | 99th |
Source: SEC filing on April 29, 2015.
Auerbach's colleagues
We found three more compensation records of executives who worked with Alan H. Auerbach at Puma Biotechnology in 2012.
2012
Richard Bryce
Puma Biotechnology
B, MRCGP and MFPM Senior Vice President, Clinical Research and Development
2012
Richard Phillips
Puma Biotechnology
Senior Vice President, Regulatory Affairs, Quality Assurance and Pharmacovigilance
2012
Charles Eyler
Puma Biotechnology